Heather Wallace

Prof. Heather Wallace

School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aber-deen AB25 2ZD, UK
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2003 in Biochemical Journal
Verified
Journal Article
Closed access
HWHeather Wallace
Heather Wallace
AFAlison V. Fraser
Alison V. Fraser
AHAlun D. Hughes
Alun D. Hughes
Polyamines are essential for the growth and function of normal cells. They interact with various macromolecules, both electrostatically and covalently and, as a consequence, have a variety of cellular effects. The complexity of polyamine metabolism and the multitude of compensatory mechanisms that are invoked to maintain polyamine homoeostasis argue that these amines are critical to cell survival. The regulation of polyamine content within cells occurs at several levels, including transcription and translation. In addition, novel features such as the +1 frameshift required for antizyme production and the rapid turnover of several of the enzymes involved in the pathway make the regulation of polyamine metabolism a fascinating subject. The link between polyamine content and human disease is unequivocal, and significant success has been obtained in the treatment of a number of parasitic infections. Targeting the polyamine pathway as a means of treating cancer has met with limited success, although the development of drugs such as DFMO (α-difluoromethylornithine), a rationally designed anticancer agent, has revolutionized our understanding of polyamine function in cell growth and provided ‘proof of concept’ that influencing polyamine metabolism and content within tumour cells will prevent tumour growth. The more recent development of the polyamine analogues has been pivotal in advancing our understanding of the necessity to deplete all three polyamines to induce apoptosis in tumour cells. The current thinking is that the polyamine inhibitors/analogues may also be useful agents in the chemoprevention of cancer and, in this area, we may yet see a revival of DFMO. The future will be in adopting a functional genomics approach to identifying polyamine-regulated genes linked to either carcinogenesis or apoptosis.

26 April 2004 in Amino Acids
Verified
Journal Article
Closed access
PDF file
HWHeather Wallace
Heather Wallace
AFA. V. Fraser
A. V. Fraser

13 July 2013 in Amino Acids
Verified
Journal Article
Closed access
PDF file
AAAhmed A. Abdulhussein
Ahmed A. Abdulhussein
HWHeather Wallace
Heather Wallace

1 January 2021 in Toxicology Reports
Verified
Journal Article
Open access
Konstantinos FarsalinosKonstantinos Farsalinos
Konstantinos Farsalinos
Konstantinos PoulasKonstantinos Poulas
Konstantinos Poulas
Dimitrios KouretasDimitrios Kouretas
Dimitrios Kouretas
Apostolos VantarakisApostolos Vantarakis
Apostolos Vantarakis
MLMichalis Leotsinidis
Michalis Leotsinidis
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
• The COVID-19 pandemic has challenged the healthcare capacity of many countries. • Strict, horizontal lockdowns have adverse social, economic and health effects that have not been fully considered. • Primary and community care have multiple roles in COVID-19 pandemic mitigation. • Greece is a case example of a country which neglected primary and community care, and in November 2020 implemented a second horizontal lockdown. • Primary and community care, represents the only realistic strategy for successful COVID-19 pandemic mitigation in the long-term.

3 December 2009 in Amino Acids
Verified
Journal Article
Closed access
PDF file
APAndrew J. Palmer
Andrew J. Palmer
HWHeather Wallace
Heather Wallace

24 April 2020 in Toxicology Research
Verified
Journal Article
Closed access
PDF file
IFIda Fischer
Ida Fischer
CMCatherine Milton
Catherine Milton
HWHeather Wallace
Heather Wallace
The efficient management of the continuously increasing number of chemical substances used in today’s society is assuming greater importance than ever before. Toxicity testing plays a key role in the regulatory decisions of agencies and governments that aim to protect the public and the environment from the potentially harmful or adverse effects of these multitudinous chemicals. Therefore, there is a critical need for reliable toxicity-testing methods to identify, assess and interpret the hazardous properties of any substance. Traditionally, toxicity-testing approaches have been based on studies in experimental animals. However, in the last 20 years, there has been increasing concern regarding the sustainability of these methodologies. This has created a real need for the development of new approach methodologies (NAMs) that satisfy the regulatory requirements and are acceptable and affordable to society. Numerous initiatives have been launched worldwide in attempts to address this critical need. However, although the science to support this is now available, the legislation and the pace of NAMs acceptance is lagging behind. This review will consider some of the various initiatives in Europe to identify NAMs to replace or refine the current toxicity-testing methods for pharmaceuticals. This paper also presents a novel systematic approach to support the desired toxicity-testing methodologies that the 21st century deserves.